Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
CDXS

Codexis, Inc. (CDXS)

NASDAQ
$1.14
+$0.06
(+6.07%)
Previous Close: ⁦$1.07⁩
Market Closed

Last updated: ⁦2026-11-19 02:51:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Codexis, Inc. (CDXS) operates in the INDUSTRIAL ORGANIC CHEMICALS sector and is listed on NASDAQ. The stock is currently priced at $1.14, with a market capitalization of $116.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $2.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$116.17M

$1.07

$1.18

$1.02

$1.07

1.25M

902.96K

--

$2.98

$0.90

--

2026-09-30

Codexis, Inc. (CDXS) Latest Closing Stock Price

Codexis, Inc. (CDXS) last closed at $1.14 as of 2026-11-19 00:44:00, up 6.07% ($0.06) from the previous close of $1.07.

During the latest regular trading session, CDXS traded between $1.02 and $1.18, with a volume of 1.25M shares. The closing price was near the upper end and near the lower end of its 52-week range.

Codexis, Inc. (CDXS) 7-Day Stock Price Change

Over the past seven days, Codexis, Inc. (CDXS) moved from $1.11 to $1.14, representing a gain of 2.43% ($0.03).

The stock traded between $0.90 and $1.20 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.26 million shares, up versus the previous seven-day period, indicating higher trading activity.

CDXS 52-Week Price Position

Position in Range: 11.4%

52W Low$0.90
52W High$2.98

CDXS is currently trading at $1.14, placing it 11.4% of the way from its 52-week low of $0.90 to its 52-week high of $2.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Codexis, Inc. (CDXS)?

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Codexis, Inc. Information

Industry
INDUSTRIAL ORGANIC CHEMICALS
Employees
146
Exchange
NASDAQ
Company Website

CDXS News

Latest news related to Codexis, Inc. and CDXS stock.

  • Benzinga

    Stephens & Co. Reiterates Overweight on Codexis, Maintains $5 Price Target

    Stephens & Co. analyst Steven Etoch reiterates Codexis (NASDAQ:CDXS) with a Overweight and maintains $5 price target.

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Friday's Intraday Session

    Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came out today. SBC

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Friday's Pre-Market Session

    Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report

    Read Full Article
  • Massive

    Codexis (CDXS) Reports Q3 Loss, Beats Revenue Estimates

    Codexis (CDXS) reported a quarterly loss of $0.08 per share, beating consensus estimates of $0.09 loss, with revenues of $19.26 million exceeding expectations by 4.16%. Despite the earnings beat and consistent outperformance over four quarters, the stock has declined 40.1% year-to-date versus the S&P 500's 11.3% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

    Read Full Article
  • Benzinga

    Codexis Q3 EPS $(0.08) Beats $(0.10) Estimate, Sales $19.262M Beat $18.720M Estimate

    Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. This is a 63.64 percent increase over losses of $(0.22) per share from the same

    Read Full Article

Ways to Trade CDXS at MEXC

CDXS MEXC RealStocks

Own real CDXS shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Codexis, Inc. (CDXS) Stock on MEXC

Eligible investors can buy real shares of Codexis, Inc. (CDXS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for CDXS and Place Your Order
Step 3: Search for CDXS and Place Your Order
Open the RealStocks trading page and search for CDXS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Codexis, Inc. (CDXS) stock price today?
Codexis, Inc. (CDXS) is currently trading at $1.14, up 6.07% ($0.06) from the previous close of $1.07. Intraday prices update in real time during regular trading hours.
2.Is CDXS stock going up or down today?
As of 2026-11-19 00:44:00, CDXS is trading at $1.14, up 6.07% ($0.06) from its previous close of $1.07. The stock has traded between $1.02 and $1.18 during today’s regular session. Past price movements do not guarantee future results.
3.What is CDXS pre-market price?
As of 2026-11-19 00:44:00, CDXS is trading at $1.07 in pre-market trading, down 0.47% ($0.01) from the previous close of $1.07. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is CDXS after-hours price?
As of 2026-11-19 00:44:00, CDXS is trading at $1.14 in after-hours trading, down 0.18% ($0.00) from the regular-session close of $1.14. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is CDXS stock trading now?
CDXS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does CDXS sit relative to its 52-week high and low?
Over the past 52 weeks, CDXS has traded between a low of $0.90 and a high of $2.98. At $1.14, the stock is positioned 11.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Codexis, Inc. in?
Codexis, Inc. (CDXS) operates in the INDUSTRIAL ORGANIC CHEMICALS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Codexis, Inc.'s market capitalization and where is it listed?
Codexis, Inc. is listed on the NASDAQ exchange with a market capitalization of $116.17M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is CDXS valued in terms of P/E ratio and EPS?
CDXS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Codexis, Inc. pay a dividend?
Codexis, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CDXS, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

CDXS Stock Calculator

Estimate the value between CDXS shares and USD.

CDXS Shares to USD

CDXS Shares
CDXS
CDXS
USD
USD
USD

1.00 CDXS shares = 1.137 USD

Calculations are estimates based on the latest available price and are for reference only.